GeneThera, Inc. 

(Public, OTC:GTHR)   Watch this stock   
Find more results for GTHR

Key stats and ratios

Q2 (Jun '09) 2008
Net profit margin - -18081.82%
Operating margin - -18081.82%
EBITD margin - -17445.46%
Return on average assets -333.75% -681.16%
Return on average equity - -
Employees 2 -

Address

3930 Youngfield Street,
Wheat Ridge, CO 80033
United States - Map
+1-303-4636371 (Phone)

Website links

External links

Discussion Group - Google Finance

Description

GeneThera, Inc. is a development-stage biotechnology company that develops molecular assays and is in the process of developing therapeutic vaccines for the detection and prevention of food contaminating pathogens, veterinary diseases, and diseases affecting human health. The Company has developed diagnostic assays for use in the agricultural and veterinary markets. Specific assays for Chronic Wasting Disease (CWD) (among elk and deer) and Mad Cow Disease (among cattle) have been developed and are available on a limited basis. E. coli (predominantly cattle) and Johne’s disease (predominantly cattle and bison) diagnostics are in development. The Company is also working on vaccine solutions to meet the demands of veterinary industry and agriculture and healthcare industries.

Officers and directors

Antonio Milici M.D., Ph.D.
Chairman of the Board, Chief Executive Officer, Chief Scientific Officer
Age: 54
Tannya L. Irizarry
Interim Chief Financial Officer, Chief Administrative Officer
Age: 49
Thomas G. Slaga
Director
Age: 67